News coverage about athenahealth (NASDAQ:ATHN) has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. athenahealth earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned press coverage about the health services provider an impact score of 47.8932649134261 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

ATHN has been the topic of a number of research analyst reports. Deutsche Bank assumed coverage on shares of athenahealth in a report on Friday, December 8th. They set a “hold” rating and a $145.00 price objective on the stock. BidaskClub downgraded shares of athenahealth from a “hold” rating to a “sell” rating in a research report on Tuesday, January 16th. KeyCorp restated a “buy” rating and set a $152.00 price target on shares of athenahealth in a research report on Friday, January 12th. ValuEngine cut shares of athenahealth from a “hold” rating to a “sell” rating in a research note on Friday, February 2nd. Finally, SunTrust Banks upped their price objective on shares of athenahealth to $180.00 and gave the company a “buy” rating in a research note on Monday, February 5th. Three analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $144.35.

Shares of athenahealth (NASDAQ ATHN) traded down $1.93 during midday trading on Wednesday, hitting $144.08. 68,456 shares of the stock were exchanged, compared to its average volume of 495,200. The stock has a market capitalization of $5,880.00, a P/E ratio of 118.19, a PEG ratio of 2.58 and a beta of 1.17. athenahealth has a 1-year low of $95.01 and a 1-year high of $158.66. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.48. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. The business had revenue of $329.20 million during the quarter, compared to the consensus estimate of $319.64 million. During the same period in the previous year, the firm posted $0.62 earnings per share. The company’s quarterly revenue was up 14.2% compared to the same quarter last year. analysts expect that athenahealth will post 2.69 EPS for the current fiscal year.

In other athenahealth news, SVP Bradford Kyle Armbrester sold 2,235 shares of the business’s stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $138.70, for a total transaction of $309,994.50. Following the completion of the sale, the senior vice president now directly owns 10,146 shares in the company, valued at $1,407,250.20. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CMO Timothy John O’brien sold 3,064 shares of the business’s stock in a transaction that occurred on Friday, March 2nd. The stock was sold at an average price of $137.27, for a total transaction of $420,595.28. Following the sale, the chief marketing officer now owns 11,320 shares of the company’s stock, valued at $1,553,896.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 108,705 shares of company stock valued at $14,891,199. 3.20% of the stock is owned by insiders.

TRADEMARK VIOLATION NOTICE: This article was reported by Marea Informative and is the sole property of of Marea Informative. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with's FREE daily email newsletter.